EMEA-001914-PIP01-15
Key facts
| Active substance |
|
| Therapeutic area |
Cardiovascular diseases
|
| Decision number |
P/0166/2016
|
| PIP number |
EMEA-001914-PIP01-15
|
| Pharmaceutical form(s) |
Film-coated tablet
|
| Condition(s) / indication(s) |
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Daewoong Pharmaceutical Co., Ltd.
Republic of Korea
Tel. +82 221906470 / +82 221906774 Fax +82 25508660 Email: gmkang294@daewoong.co.kr / oscar23@daewoong.co.kr |
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|